Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001562180-25-000031

CEO bought 5,000 shares at $1.21 ($6,044)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vaddi Krishna CEO 2024-12-31 Purchase +5,000 $1.21 $6,044 142,553 I
Open-market purchases · 5,000 sh · avg $1.21 · $6,044
Loading xslF345X05/primarydocument.xml…